ad3418b026f6c3a5dbf4028ee509d6dd.jpg

Stratasys FY2016 losses reduced significantly, slow business improvement AM Industry

Stratasys, the current 3D printing industry market leader in terms of global sales, reported revenues $672.5 million in Stratasys FY2016 results compared to $696.0 million for fiscal 2015. This relatively contained decrement came with a huge reduction in GAAP net losses: $77.2 million, or ($1.48) per diluted share, compared to $1.4 billion, or ($26.64) per diluted share, for fiscal 2015.

1b1a072fab3d56a70f9387031f7180de.jpg

Siemens sets milestone with first 3D printed part operating in a nuclear power plant 3D Printing Processes

Following the integration of 3D printing as part of its digital services portfolio, Siemens has achieved an industry breakthrough with the first successful commercial installation and continuing safe operation of a 3D printed part in a nuclear power plant. Because of the stringent safety and reliability requirements in the nuclear sector, achieving this qualification is a significant accomplishment.

a9bd79ef9a69352aa7c54735e1afe2af.jpg

Stratasys Opens Enrollment for 3DHEART Clinical Study on Effects of 3D Printed Heart Models in Surgery Medical

Stratasys, the 3D printing and additive manufacturing solutions market leader, today announced enrollment is now open for 3DHEART, an investigator initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3D printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.

a9bd79ef9a69352aa7c54735e1afe2af.jpg

Stratasys Opens Enrollment for 3DHEART Clinical Study on Effects of 3D Printed Heart Models in Surgery 3D Printing Processes

Stratasys, the 3D printing and additive manufacturing solutions market leader, today announced enrollment is now open for 3DHEART, an investigator initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3D printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.